References
- Machova PolakovaKKoblihovaJStopkaTRole of epigenetics in chronic myeloid leukemiaCurr Hematol Malig Rep201381283623296408
- MarcheseFPHuarteMLong non-coding RNAs and chromatin modifiers: their place in the epigenetic codeEpigenetics201491212624335342
- WangLDowellRDYiRGenome-wide maps of polyadenylation reveal dynamic mRNA 3’-end formation in mammalian cell lineagesRNA201319341342523325109
- KimSYamamotoJChenYEvidence that cleavage factor Im is a heterotetrameric protein complex controlling alternative polyadenylationGenes Cells20101591003101320695905
- MasamhaCPXiaZYangJCFIm25 links alternative polyadenylation to glioblastoma tumour suppressionNature2014510750541241624814343
- MayrCRegulation by 3’-Untranslated RegionsAnnu Rev Genet20175117119428853924
- RouthAJiPJaworskiEXiaZLiWWagnerEJPolyWEJPoly(A)-ClickSeq: click-chemistry for next-generation 3′-end sequencing without RNA enrichment or fragmentationNucleic Acids Res20174512e11228449108
- FusbyBKimSEricksonBKimHPetersonMLBentleyDLCoordination of RNA Polymerase II Pausing and 3’ End Processing Factor Recruitment with Alternative PolyadenylationMol Cell Biol201636229530326527620
- SartiniBLWangHWangWMilletteCFKilpatrickDLPre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesisBiol Reprod200878347248218032416
- GennarinoVAAlcottCEChenCANUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylationeLife201542 eLife.10782
- ZhuZJHuangPChongYXMicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcomaMol Med Rep20161454271427827633853
- LouJCLanYLGaoJXSilencing NUDT21 Attenuates the Mesenchymal Identity of Glioblastoma Cells via the NF-κB PathwayFront Mol Neurosci20171042029311812
- Erson-BensanAECanTAlternative Polyadenylation: Another Foe in CancerMol Cancer Res201614650751727075335
- RedisRSVelaLELuWAllele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2Mol Cell201661452053426853146
- SzczepanekJStyczyńskiJTretynAPogorzałaMWysockiMIdentification of the genes expression profile associated with the ex vivo resistance to etoposide in childhood acute leukemiasPostepy Hig Med Dosw201266401408
- ChenJOdenikeORowleyJDLeukaemogenesis: more than mutant genesNat Rev Cancer2010101233620029422
- LeeSCAbdel-WahabOTherapeutic targeting of splicing in cancerNat Med201622997698627603132
- XiangKTongLManleyJLDelineating the structural blueprint of the pre-mRNA 3’-end processing machineryMol Cell Biol201434111894191024591651
- ZhaoJHymanLMooreCFormation of mRNA 3’ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesisMicrobiol Mol Biol Rev199963240544510357856
- DanckwardtSHentzeMWKulozikAE3’ end mRNA processing: molecular mechanisms and implications for health and diseaseEMBO J200827348249818256699
- JiZLeeJYPanZJiangBTianBProgressive lengthening of 3’ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic developmentProc Natl Acad Sci U S A2009106177028703319372383
- SandbergRNeilsonJRSarmaASharpPABurgeCBProliferating cells express mRNAs with shortened 3’ untranslated regions and fewer microRNA target sitesScience200832058831643164718566288
- BrumbaughJdi StefanoBWangXNudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin SignalingCell20181721–210612029249356
- GennarinoVAAlcottCEChenCANUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylationElife201544